Universe Pharmaceuticals INC
UPC · XNASCIK 1809616fmd_0WQE2PA9K9H8APJVA4KGTBNK40Industri Pengolahan · Sediaan FarmasiTemplat: Standar
Cakupan: 01 Okt 2018 hingga 30 Sep 2025, 11 periode
| Pos laporan | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total pendapatan | 33 | 31 | 48 | 40 | 32.309 | 23.024 | 17.859 |
| Beban pokok pendapatan | 20 | 17 | 23 | 18 | 21.994 | 16.953 | 11.558 |
| Pendapatan investasi bersih | 0 | 0 | 0 | 0 | 0 | – | – |
| Laba kotor | 13 | 14 | 25 | 22 | 10.315 | 6.072 | 6.301 |
| Penelitian dan pengembangan | 1 | 1 | 5 | 8 | 4.859 | 3.031 | 672 |
| Total beban operasi | 4 | 4 | 12 | 29 | 14.281 | 14.092 | 9.217 |
| Laba operasi | 10 | 10 | 14 | (7) | (3.966) | (8.020) | (2.916) |
| Beban bunga | 0 | 0 | 0 | 0 | 190 | 305 | 289 |
| Pendapatan (beban) nonoperasi lainnya | (0) | (0) | 0 | (0) | (361) | (101) | (756) |
| Laba sebelum pajak | 10 | 10 | 14 | (7) | (4.327) | (8.121) | (3.672) |
| Beban pajak penghasilan | 2 | 3 | 2 | 1 | 2.254 | 607 | – |
| Laba bersih dari operasi yang dilanjutkan | 8 | 8 | 11 | (8) | (6.581) | (8.727) | – |
| Laba bersih | 8 | 8 | 11 | (8) | (6.581) | (8.727) | (3.672) |